Search Results - Jose Molto

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Status Epilepticus with Fever in a Toddler with Pyogenic Meningitis Due to Complicated Acute Sphenoid Sinusitis by Jay Pershad, MD, Lexi Crawford, MD, Diego Preciado, MD, Dana Harrar, MD, Jose Molto, MD, Craig Shapiro, MD

    Published in Journal of Pediatrics: Clinical Practice (2024-12-01)
    Get full text
    Article


  2. 2

    Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile. by José R Santos, José Moltó, Josep M Llibre, Eugenia Negredo, Isabel Bravo, Arelly Ornelas, Bonaventura Clotet, Roger Paredes

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  3. 3

    Interactions between gut microbiota, plasma metabolome and brain function in the setting of a HIV cure trial by Alessandra Borgognone, Anna Prats, Anna Prats, Ashish Arunkumar Sharma, Ignacio Martinez-Zalacaín, Ignacio Martinez-Zalacaín, Carles Soriano-Mas, Carles Soriano-Mas, Carles Soriano-Mas, Christian Brander, Christian Brander, Christian Brander, Christian Brander, Bonaventura Clotet, Bonaventura Clotet, Bonaventura Clotet, Bonaventura Clotet, Bonaventura Clotet, José Moltó, José Moltó, José Moltó, Beatriz Mothe, Beatriz Mothe, Beatriz Mothe, Beatriz Mothe, Beatriz Mothe, Rafick-Pierre Sekaly, Roger Paredes, Roger Paredes, Roger Paredes, Roger Paredes, Roger Paredes, Roger Paredes, Roger Paredes, Jose A. Muñoz-Moreno, Jose A. Muñoz-Moreno, Jose A. Muñoz-Moreno

    Get full text
    Article


  4. 4

    Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy. by Maria C Puertas, Lucía Bailón, Víctor Urrea, Maria C García-Guerrero, Yovaninna Alarcón-Soto, Angel Rivero, Beatriz Mothe, José Moltó, Javier Martinez-Picado, DUALITY study group

    Published in PLoS Pathogens (2025-09-01)
    Get full text
    Article


  5. 5

    Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study. by José R Santos, José A Muñoz-Moreno, José Moltó, Anna Prats, Adrià Curran, Pere Domingo, Josep M Llibre, Daniel R McClernon, Isabel Bravo, Jaume Canet, Victoria Watson, David Back, Bonaventura Clotet

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  6. 6

    Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study by Juan Ambrosioni, Natalia Anahí Díaz, Catia Marzolini, Gordana Dragovic, Arkaitz Imaz, Andrea Calcagno, Sonia Luque, Adrian Curran, Jesus Troya, Montse Tuset, Saye Khoo, David Burger, Claudia P. Cortés, Nadia Naous, Jose Molto

    Published in Infectious Diseases and Therapy (2024-02-01)
    Get full text
    Article


  7. 7

    Rare case of extralymphatic dirofilariasis presenting as a facial subcutaneous nodule in non-endemic region of Spain by Asuncion Maria Gonzálvez-Gasch, Guzman Lopardo Villarino, Enrique Bernal Morell, José Moltó Marhuenda, Raquel Martínez Goñi, Marta Rolo Téllez, Maria Carmen Martín-Higuera, Rosa Maria Cañon Rodríguez, Juan Enrique Costell, Marta Valles Bergada

    Published in IDCases (2025-01-01)
    Get full text
    Article


  8. 8

    Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results by María Jesús López Fernández, Silvia Narejos, Antoni Castro, José María Echave-Sustaeta, María José Forner, Eunate Arana-Arri, José Molto, Laia Bernad, Raúl Pérez-Caballero, Julia G. Prado, Dàlia Raïch-Regué, Rytis Boreika, Nuria Izquierdo-Useros, Benjamin Trinité, Julià Blanco, Joan Puig-Barberà, Silvina Natalini Martínez

    Published in Vaccines (2024-07-01)
    Get full text
    Article


  9. 9

    Safety and immunogenicity of PHH-1V booster against SARS-CoV-2 variants, including omicron subvariants: Results from a phase IIb open-label extension study by María Jesús López, Maria Del Mar Vazquez, Melchor Alvarez-Mon, José Ramón Arribas, Eunate Arana-Arri, Patricia Muñoz, Jorge Navarro-Pérez, Rafael Ramos, José Molto, Susana Otero-Romero, Elena Aurrecoechea, Roc Pomarol, Laia Bernad, Ignasi Esteban, Raúl Pérez-Caballero, Montserrat Plana, Júlia G. Prado, Álex Soriano

    Published in Human Vaccines & Immunotherapeutics (2025-12-01)
    Get full text
    Article


  10. 10

    Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM) by José Luis Manzano, Ivan Marquez-Rodas, Cristina Carrera, Mario Mandala, Eva Muñoz-Couselo, Maria Gonzalez-Cao, Teresa Puertolas, Mar Riveiro, Carolina Ortiz, Roger Paredes, Daniel Podzamczer, Jose Molto, Boris Revollo, Lourdes Mateu, Sara Fancelli, Enrique Espinosa, Bonaventura Clotet, Javier Martinez-Picado, Pablo Cerezuela, Ainara Soria, Alfonso Berrocal

    Published in Journal for ImmunoTherapy of Cancer (2021-03-01)
    Get full text
    Article


  11. 11

    Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial by Lucia Bailón, José Moltó, Adrian Curran, Julen Cadiñanos, Juan Carlos Lopez Bernaldo de Quirós, Ignacio de Los Santos, Juan Ambrosioni, Arkaitz Imaz, Susana Benet, Paula Suanzes, Jordi Navarro, Juan González-García, Carmen Busca, Leire Pérez-Latorre, Juan Berenguer, Lucio Jesús García-Fraile, Gina Mejía-Abril, Jose M. Miró, Sofía Scévola, Santiago Moreno, Pere Domingo, Yuan Tian, Michelle Frankot, Daina Lim, Yanhui Cai, Elena Vendrame, Susan Guo, Jeffrey J. Wallin, Romas Geleziunas, Devi SenGupta, Yovaninna Alarcón-Soto, Isabel Leal, Alvaro Aranguen, Margarida Garcia-Garcia, Ian McGowan, Christian Brander, Jose Ramón Arribas, Beatriz Mothe, On behalf of the AELIX-003 Study Group

    Published in Nature Communications (2025-03-01)
    Get full text
    Article


  12. 12

    Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B... by Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, Kristin Greve-Isdahl Mohn, Antonio-José Carcas-Sansuan, Esperanza Romero Rodriguez, José Moltó, Itziar Vergara Mitxeltorena, Tobias Welte, Birutė Zablockienė, Murat Akova, Ullrich Bethe, Sarah Heringer, Jon Salmanton-García, Julia Jeck, Lea Tischmann, Marouan Zarrouk, Arnd Cüppers, Lena M. Biehl, Jan Grothe, Sibylle C. Mellinghoff, Julia A. Nacov, Julia M. Neuhann, Rosanne Sprute, Jesús Frías-Iniesta, Riya Negi, Colette Gaillard, Gurvin Saini, Alejandro García León, Patrick W.G. Mallon, Christine Lammens, An Hotterbeekx, Katherine Loens, Surbhi Malhotra-Kumar, Herman Goossens, Samir Kumar-Singh, Franz König, Martin Posch, Philipp Koehler, Oliver A. Cornely

    Get full text
    Article


  13. 13

    SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial) by Sofía Sábato, Susana Benet, Angela J. Rogers, Thomas A. Murray, Melissa Skeans, Beatriz Mothe, Roger Paredes, Ahmad Mourad, Francis Kiweewa, Dena Kamel, Mamta K. Jain, Joseph Lutaakome, Mary Grace Nalubega, Nicholus Sebudde, Eleftherios Mylonakis, Dominique L. Braun, Timothy Hatlen, Ivan Kimuli, Cissy Kitko, Henry Mugerwa, Jonathan Kitonsa, Kami Kim, Phyllis C. Tien, Jeroen Highbarger, Ashley L. McCormack, Adriana Sanchez, Daniel D. Murray, Abdel G. Babiker, Victoria J. Davey, D. Clark Files, Annetine C. Gelijns, Elizabeth S. Higgs, Virginia L. Kan, Gail V. Matthews, Sarah L. Pett, H. Clifford Lane, Cavan Reilly, Anna L. Goodman, Jens D. Lundgren, José Moltó, the ACTIV-3/VATICO study group and the STRIVE Network

    Published in Scientific Reports (2025-03-01)
    Get full text
    Article


Search Tools: